Preclinical and early phase clinical studies have demonstrated pharmacokinetic performance comparable to or exceeding conventional subcutaneous delivery for insulin, GLP-1 analogs, and selected therapeutic proteins, as well as enhanced immunogenicity for vaccines
Health companies market them as easier alternatives, promising the same benefits as GLP-1 medications in a stick-on patch you can order online without a prescription
Feeling full quickly due to slow gastric emptying can lead to eating less overall, unintentionally reducing protein and resistance training fuel
A different take on obesity treatment GLP-1 drugs like semaglutide (the active ingredient of Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro) have revolutionized obesity treatment in recent years
People with eating disorders also are at vastly increased risk of having a substance use disorder compared to the general population, he said
Future trials should prioritize centrally penetrant molecules and incorporate biomarker driven, biologically enriched designs